Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE CAPSULES safely and effectively. See full prescribing information for DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE CAPSULES. DEXTROMETHORPHAN HYDROBROMIDE and QUINIDINE SULFATE capsules, for oral use Initial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
Dextromethorphan hydrobromide and quinidine sulfate capsules are indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the underlying emotional state. PBA is a specific condition, distinct from other types of emotional lability that may occur in patients with neurological disease or injury.
- generic_name
- dextromethorphan hydrobromide and quinidine sulfate
- product_names
- Dextromethorphan hydrobromide and quinidine sulfate
- ndc
- 31722-693, 31722-693-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en